SHLD (Global X Defense Tech ETF) Stock Analysis - News

Global X Defense Tech ETF (SHLD) is a publicly traded the market company. As of May 21, 2026, SHLD trades at $64.60 with a market cap of $0 and a P/E ratio of 0.00. SHLD moved +0.86% today. Year to date, SHLD is +0.00%; over the trailing twelve months it is flat. Its 52-week range spans $0.00 to $0.00. Rallies surfaces SHLD's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What changed in SHLD news today?

Renk 2025 Revenue Jumps 19.8% to €1.37B, Guides Below Forecast: Renk posted €1.37 billion in fiscal 2025 revenue, up 19.8%, and adjusted operating profit rose 21% to €230 million as defense sales made up 75% of total. Order intake hit €1.57 billion, pushing backlog to €6.7 billion, but shares dropped 8% after management guided 2026 revenue at about €1.5 billion, below expectations.

SHLD Key Metrics

Key financial metrics for SHLD
MetricValue
Price$64.60
Market Cap$0
P/E Ratio0.00
EPS$0.00
Dividend Yield0.00%
52-Week High$0.00
52-Week Low$0.00
Volume1.85M
Avg Volume0
Revenue (TTM)$0
Net Income$0
Gross Margin0.00%

Latest SHLD News

SHLD Analyst Consensus

SHLD analyst coverage data. Average price target: $0.00.

Common questions about SHLD

What changed in SHLD news today?
Renk 2025 Revenue Jumps 19.8% to €1.37B, Guides Below Forecast: Renk posted €1.37 billion in fiscal 2025 revenue, up 19.8%, and adjusted operating profit rose 21% to €230 million as defense sales made up 75% of total. Order intake hit €1.57 billion, pushing backlog to €6.7 billion, but shares dropped 8% after management guided 2026 revenue at about €1.5 billion, below expectations.
Does Rallies summarize SHLD news?
Yes. Rallies summarizes SHLD news with ticker-specific context, catalysts, source links, and AI-generated market summaries when news is available.
Is SHLD research on Rallies investment advice?
No. Rallies provides research, data, and educational context for SHLD. It does not provide personalized investment advice.
SHLD

SHLD